National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/12/2021 release of VAERS data:

Found 203 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 11 out of 21

Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next


VAERS ID: 1481295 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: California  
Vaccinated:0000-00-00
Onset:2021-04-01
Submitted: 0000-00-00
Entered: 2021-07-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Several underlying condition
Allergies:
Diagnostic Lab Data: Test Date: 202105; Test Name: Lumbar puncture; Result Unstructured Data: Guillain-Barre Syndrome; Test Date: 202105; Test Name: MRI; Result Unstructured Data: Guillain-Barre Syndrome
CDC Split Type: USJNJFOC20210732228

Write-up: GUILLAIN-BARRE SYNDROME; This spontaneous report received from a patient via a company representative via traditional media news concerned a 46 year old female, race and ethnicity not reported. The patient''s height, and weight were not reported. The patient''s past medical history included several underlying conditions (no further information provided). The patient has a teen-age child. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The patient suffered no immediate side effects. A week post vaccination in APR-2021, her feet started to hurt and then her legs. Days later, she woke up with intense neck pain. After an hour, her face felt funny. Patient went to bathroom and looked in the mirror. Her face was completely frozen and droopy. A trip to hospital (date unspecified) produced no answers. Five days later, she was walking back from the bathroom, she fell and was completely paralyzed from waist down. In mid-MAY, an MRI and spinal tap revealed diagnosis of Guillain-Barre syndrome (GBS). Months later (date unspecified), patient''s many symptoms have improved. The patient needs a walker and can only eat pureed foods. Her doctors have told her that her symptoms may disappear ''next week'' but condition can be permanent. Since past few days (dates unspecified), patient''s muscle weakness worsened and she may require blood transfusion and plasma replacement therapy. It was reported that the patient had many underlying conditions but none were associated with GBS. According to the patient, the neurologist believed events were due to the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The event Guillain-Barre syndrome was not recovered. This report was serious (Disability Or Permanent Damage).; Sender''s Comments: V0: This spontaneous report from a patient via traditional media concerns a 46 year-old female with "many" unspecified underlying conditions who was diagnosed with Guillain-Barre Syndrome (GBS) in the month following vaccination with Janssen Covid-19 vaccine. Concomitant medications were not reported. The patient initially did not experience any adverse events. One week post-vaccination, she experienced pain in her feet and then in her legs. An unspecified number of days later, she awoke with intense neck pain and then her face became "completely frozen and droopy" one hour later. She went to the hospital but did not receive answers. Five days later, she fell while walking and was "completely paralyzed" from the waist down. An MRI and spinal tap performed on unspecified dates diagnosed GBS. Months later, many of her symptoms have improved but she still requires a walker and can only eat pureed foods. In the past few days, her muscle weakness has worsened which may require blood transfusion and plasma replacement therapy. The patient reported that her neurologist believes the events are due to the vaccine. Considering the missing information (e.g. medical history, MRI & cerebrospinal fluid results, corrective treatment) and the temporal relationship, the events are assessed to have an indeterminate relationship with vaccination.


VAERS ID: 1481305 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Lumbar puncture
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 22 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data: Test Date: 202106; Test Name: Spinal tap; Result Unstructured Data: confirmed Guillain-Barre syndrome
CDC Split Type: USJNJFOC20210733585

Write-up: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient via news media article, via a company representative and concerned a female of unspecified age, race and ethnicity. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) " about three months ago", dose and vaccination site were not reported, for prophylactic vaccination. Batch number was not reported. Company unable to conduct follow up to obtain batch number. No concomitant medications were reported. On an unspecified date in JUN-2021, the patient experienced Guillain-Barre syndrome and was hospitalized (date unspecified). In JUN-2021, patient started feeling numbness and tingling in her hands and feet; "it was pretty fast moving up the legs to my hips where I was numb from the waist down and then your arms and your fingers". The patient went to different doctors and were told ''you are dehydrated'' and ''you are fine''. Patient was told she had anxiety. Patient condition worsened, eventually affecting her ability to walk. She started falling and eventually ended up being paralyzed from the waist down. She went to the emergency room twice before she found out that she had Guillain-Barre syndrome. After a spinal tap confirmed her diagnosis, she was hospitalized for 22 days, treated with unspecified medications and slowly regained feeling in her lower body. Patient underwent physical therapy "to learn how to walk again and how to sit". At the time of report, she was still using a walker to get around and still had numbness and tingling in her hands and feet. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from Guillain-Barre syndrome. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: This spontaneous report from a patient via news media concerns a female of unknown age who was hospitalized and diagnosed with Guillain-Barre Syndrome (GBS) approximately 2 months after receiving the Janssen Covid-19 vaccine. Medical history and concomitant medications were not reported. Symptoms started with numbness and tingling in her hands and feet which moved quickly up the legs to her hips and she became numb from the waist down. She consulted different doctors but did not receive a diagnosis. Her condition worsened to point of affecting her ability to walk. She started falling and became paralyzed from the waist down. She went to the emergency room twice and received a spinal tap which confirmed her diagnosis of GBS. She was hospitalized for 22 days and received unspecified treatment. She also underwent physical therapy to learn how to walk again and how to sit. At the time of report, she was still using a walker to get around and still had numbness and tingling in her hands and feet. Information is limited in this case (e.g. missing age, medical history, concomitant medications, diagnostic test results, corrective treatment). Therefore, the relationship of the event to vaccination is considered unclassifiable due to insufficient information.


VAERS ID: 1481630 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-06-05
Onset:2021-06-23
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-07-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Back pain, Blood glucose normal, Borrelia test positive, CSF cell count normal, CSF protein increased, Chills, Computerised tomogram head normal, Cough, Facial paralysis, Guillain-Barre syndrome, Headache, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging spinal normal, Malaise, Muscular weakness, Protein total, Pyrexia, Rash
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (narrow), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tylenol
Current Illness: none
Preexisting Conditions: GERD Paroxysmal atrial fibrillation
Allergies: Penicillin- rash
Diagnostic Lab Data: CT Brain, MRI thoracic and lumbar spine normal. CSF normal cell count, glucose 66, protein 142.
CDC Split Type:

Write-up: Presented with generalized malaise, fever, chills on June 23. Had headache and cough on and off after receving vaccine. On July 8 admitted to hospital with rash concerning for erythema migrans. Positive Lyme IgM. Started doxycycline. Discharged 7/10. Came back on 7/11 with bilateral facial nerve palsy. noted to have severe back pain of unclear cause as well. Started on Ceftriaxone. Discharged again on 7/13. On 7/14 presented to oupatient ID clinic with increasing back pain and numbness on trunk and upper thighs. Sent back to hospital. CT head, MRI thoracic and lumbar spine normal. LP done normal cell count, mildly elevated protein on CSF. Increasing muscle weakness of extremities (proximal muscles of lower extremities first). Impression: Guillain Barre. Started on IVIG


VAERS ID: 1484763 (history)  
Form: Version 2.0  
Age: 50.0  
Sex: Male  
Location: California  
Vaccinated:2021-06-01
Onset:2021-07-01
   Days after vaccination:30
Submitted: 0000-00-00
Entered: 2021-07-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Back pain, Blood test abnormal, Diplegia, Diplopia, Dysuria, Facial paralysis, Frequent bowel movements, Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture abnormal, Magnetic resonance imaging abnormal, Miller Fisher syndrome, Vision blurred
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Demyelination (narrow), Lens disorders (broad), Retinal disorders (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hearing impairment (broad), Ocular motility disorders (narrow), Noninfectious diarrhoea (narrow), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 12 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Carbamazepine
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Two MRIs, three spinal taps, blood work
CDC Split Type:

Write-up: Acute back pain leading to numbness in both legs causing paralysis in both legs, facial paralysis, blurred and double vision, trouble urinating and having bowel movements. Has been diagnosed with GBS/ Miller-fisher disease.


VAERS ID: 1484897 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Female  
Location: Alabama  
Vaccinated:2021-03-24
Onset:2021-04-18
   Days after vaccination:25
Submitted: 0000-00-00
Entered: 2021-07-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808978 / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Gait inability, Guillain-Barre syndrome, Laboratory test, Lumbar puncture
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Gabapentin, Omeprazole, Paxil, Seroquel, Restoril, otc Potassium
Current Illness: none
Preexisting Conditions: Bipolar Disorder, hyperlipidemia, GERD, insomnia, neuropathy
Allergies: hydrocodone, PCN, codeine
Diagnostic Lab Data: multiple labs; 2 hospitalizations; spinal tap
CDC Split Type:

Write-up: Guillain Barre Syndrome- continues symptomatic; unable to walk.


VAERS ID: 1489538 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210733910

Write-up: GUILLAIN-BARRE SYNDROME; This spontaneous report received from a health care professional via social media via company representative concerned a male patient of unspecified age. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for an unspecified indication. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. On an unspecified date, the subject experienced Guillain-Barre syndrome. The reporter had a patient last week who now had this syndrome four weeks after taking the vaccine and can barely walk or ''hold in anything" This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: This spontaneous report received via social media post concerns a male patient of unspecified age and ethnicity who had Guillain-Barre syndrome 4 weeks after receiving the Janssen Covid-19 vaccine. The patient was reported as "can barely walk" or ?hold in anything". No other pertinent details reported. The information available precludes a complete and meaningful assessment. Based on the information available, and the occurrence of GBS could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.


VAERS ID: 1489574 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Pain
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210740849

Write-up: GUILLAIN-BARRE SYNDROME; PAIN; This spontaneous social media report via Johnson and Johnson was received from a consumer via a company representative and concerned a female patient of unspecified age, race and ethnicity. The patient''s weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number unknown), dose and vaccination date not reported, for prophylactic vaccination. The company is unable to perform follow-up to obtain the batch number. No concomitant medications were reported. The consumer reported that, on unspecified dates, that their aunt ''after days of pain and sending her home 3 times'' (not reported what type of facility sent the patient home), she was diagnosed with Guillain-Barre syndrome ''as a reaction to the vaccine''.. The action taken with COVID-19 vaccine Ad26.CoV2.S was not applicable. The outcome of the pain and Guillain-Barre syndrome was not reported. This report was serious (other medically important condition).; Sender''s Comments: V0: This spontaneous report received from a consumer via social media concerns a female of unknown age, race, and ethnicity who was diagnosed with Guillain-Barre syndrome (GBS) an unspecified period of time after receiving the Janssen Covid-19 vaccine. Medical history, concomitant medications, clinical symptoms, diagnostic testing, corrective treatment, and outcome were not reported. Information is limited in this case. Therefore, the relationship of GBS to vaccination is considered unclassifiable due to insufficient information. More information will be requested if contact information is available.


VAERS ID: 1490561 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Male  
Location: Nebraska  
Vaccinated:2021-04-08
Onset:2021-04-20
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808980 / 1 AR / SYR

Administered by: School       Purchased by: ?
Symptoms: Blood test, Computerised tomogram, Depressed mood, Diplegia, Dysstasia, Electromyogram abnormal, Gait inability, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Infection, Loss of personal independence in daily activities, Magnetic resonance imaging abnormal, Magnetic resonance imaging head, Magnetic resonance imaging neck, Magnetic resonance imaging thoracic, Malaise, Muscular weakness, Nerve injury, Pain in extremity, Pyrexia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Depression (excl suicide and self injury) (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 120 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: none
Preexisting Conditions:
Allergies: none
Diagnostic Lab Data: GILLIAN BARRE syndrome All Dates in Item 18!
CDC Split Type:

Write-up: april 20th his foot started to hurt, April 21st his legs felt slightly weak, April23 & 24th felt sick had a hard time getting out of bed and dressing. April25th felt numb mid body and legs really weak had a hard time standing took him to the ER had a MRI on Back and Bloodwork done. April 26th saw his doctor ordered another MRI for head and neck. April 27th had MRI for head and neck. April 28th rushed to hospital symptoms got worse and was admitted also had a CAT scan and an MRI again. April 29th another MRI was diagnosed with GILLIAN-BARRE syndrome. Had six doses of IGG transfusions May 6th moved to rehab. was in Therapy till June 10th and Back to the hospital for 5 more treatments because his legs quit working again. WAs in the hospital for a week and then insurance denied therapy so had to find skilled nursing, found one moved him . He was at his new place maybe 8 hours then rushed back to the Hospital because a fever and may had an infection had medician to help get rid of that lost his facility he came from and then took a week to find another place he was there 3 weeks and had a EMG and the nerves in is legs are Damaged in and out so he will take a long time to heal and walk again and he is also very depressed because the whole situation.


VAERS ID: 1490563 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-06-20
Onset:2021-07-04
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Back pain, CSF protein increased, Dysaesthesia, Dyspnoea, Guillain-Barre syndrome, Lumbar puncture, Pain, Pain in extremity, Paraesthesia
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Cardiomyopathy (broad), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Developed back pain and pain in her torso that spread to the extremities, starting on 7/8. She then developed paresthesias, dysesthesia, and shortness of breath. LP showed elevated protein. The patient has been diagnosed with AIDP/Guillian-Barre.


VAERS ID: 1491651 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-04-09
Onset:2021-04-30
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Antinuclear antibody positive, Autoimmune disorder, Blood test abnormal, Dyspnoea, Guillain-Barre syndrome, Hypoaesthesia
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Systemic lupus erythematosus (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Cardiomyopathy (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Blood work done on may 22 that tested positive for autoimmune disorder and ANA
CDC Split Type:

Write-up: Numbness in feet that spread to legs, trouble breathing?. Was given inhaler?. Neurologist said it was a mild case of guillain-barr?


Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=11&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166